Article
The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut…
Drug Design, Development and Therapy · 2019 · Zhang DY, Zhu L, Liu HN, Tseng YJ, Weng SQ, Liu TT, Dong L, Shen XZ
Key facts
| Title | The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease |
|---|---|
| First author | Zhang DY, Zhu L, Liu HN, Tseng YJ, Weng SQ, Liu TT, Dong L, Shen XZ |
| Journal | Drug Design, Development and Therapy |
| Published | Jul 5, 2019 |
| DOI | 10.2147/DDDT.S207277 |
| Devices mentioned | 090114, K071580 |
| Product codes mentioned | CIT, JCJ, LXG |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1